National Health Investors (NYSE:NHI) Releases FY 2026 Earnings Guidance

National Health Investors (NYSE:NHIGet Free Report) updated its FY 2026 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 4.740-4.790 for the period, compared to the consensus estimate of 5.020. The company issued revenue guidance of -.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the stock. National Bank Financial set a $85.00 price objective on shares of National Health Investors in a report on Tuesday, January 20th. Deutsche Bank Aktiengesellschaft lowered shares of National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 price target on the stock. in a research note on Tuesday, January 20th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of National Health Investors in a research note on Friday, March 27th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $94.00 price objective on shares of National Health Investors in a report on Wednesday, April 22nd. Finally, Truist Financial lowered their price objective on shares of National Health Investors from $92.00 to $89.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have given a Hold rating to the company. According to MarketBeat, National Health Investors currently has an average rating of “Moderate Buy” and an average target price of $87.50.

Read Our Latest Research Report on NHI

National Health Investors Stock Down 1.4%

Shares of NYSE NHI traded down $1.06 during midday trading on Monday, reaching $75.66. The company’s stock had a trading volume of 561,098 shares, compared to its average volume of 301,136. The company has a current ratio of 6.90, a quick ratio of 6.90 and a debt-to-equity ratio of 0.76. National Health Investors has a fifty-two week low of $68.80 and a fifty-two week high of $91.38. The stock has a market capitalization of $3.67 billion, a price-to-earnings ratio of 25.05, a PEG ratio of 4.18 and a beta of 0.55. The stock has a 50 day simple moving average of $83.79 and a 200-day simple moving average of $80.56.

National Health Investors (NYSE:NHIGet Free Report) last posted its quarterly earnings data on Monday, May 4th. The real estate investment trust reported $0.82 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.85 by ($0.03). National Health Investors had a net margin of 37.81% and a return on equity of 9.56%. The business had revenue of $115.13 million during the quarter, compared to analyst estimates of $70.22 million. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Equities research analysts predict that National Health Investors will post 5.02 earnings per share for the current year.

National Health Investors Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, May 1st. Investors of record on Tuesday, March 31st were paid a $0.92 dividend. The ex-dividend date of this dividend was Tuesday, March 31st. This represents a $3.68 annualized dividend and a dividend yield of 4.9%. National Health Investors’s dividend payout ratio (DPR) is currently 121.85%.

Hedge Funds Weigh In On National Health Investors

Hedge funds and other institutional investors have recently made changes to their positions in the company. Federation des caisses Desjardins du Quebec grew its stake in shares of National Health Investors by 29.5% in the fourth quarter. Federation des caisses Desjardins du Quebec now owns 3,755 shares of the real estate investment trust’s stock valued at $287,000 after buying an additional 855 shares in the last quarter. Ieq Capital LLC bought a new position in shares of National Health Investors in the fourth quarter valued at $240,000. Cibc World Markets Corp bought a new position in shares of National Health Investors in the fourth quarter valued at $238,000. Boothbay Fund Management LLC bought a new position in shares of National Health Investors in the fourth quarter valued at $213,000. Finally, Orion Porfolio Solutions LLC bought a new position in shares of National Health Investors in the fourth quarter valued at $212,000. 62.51% of the stock is owned by institutional investors.

National Health Investors Company Profile

(Get Free Report)

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.

Featured Articles

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.